The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells

Document type :
Journal articles
Complete list of metadatas

https://hal.archives-ouvertes.fr/hal-02344706
Contributor : Isabelle Broutin <>
Submitted on : Monday, November 4, 2019 - 11:50:00 AM
Last modification on : Tuesday, November 19, 2019 - 2:37:29 AM

Links full text

Identifiers

Citation

Rosamaria Lappano, Christophe Mallet, Bruno Rizzuti, Fedora Grande, Giulia Galli, et al.. The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells. Cells, MDPI, 2019, 8 (6), pp.590. ⟨10.3390/cells8060590⟩. ⟨hal-02344706⟩

Share

Metrics

Record views

14